Log in

Laboratory Diagnostics of Ovarian Cancer among the Elderly Based on the Parameters of Immunoglobulins and Phagocytic Activity of Blood

  • Published:
Advances in Gerontology Aims and scope Submit manuscript

Abstract

New diagnostic methods are being sought for ovarian cancer due to its higher prevalence, which is the result of an increase in the share of elderly women. The purpose of this study was to analyze the content and sensitivity of immunoglobulins and the phagocytic activity of peripheral blood in order to improve the diagnostics of ovarian cancer among elderly women. The phagocytic activity and the immunoglobulin level in the peripheral blood were assessed with immunological and spectrophotometric methods in 78 patients with ovarian cancer aged 65–70 years. The control group comprised 42 women of the same age with no ovarian cancer. The primary importance of circulating immune complexes and the indices of neutrophil activity and the inhibition of phagocyte migration was established for laboratory diagnostics of ovarian cancer among elderly people. The use of highly informative parameters of systemic immunity may enhance the diagnostics of ovarian cancer in the elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Abakumova, T.V. and Antoneeva, I.I., Nonspecific cellular immunity at different stages of cervical cancer, Ul’yanovsk. Med.-Biol. Zh., 2012, no. 2, pp. 104–110.

  2. Agarkov, N.M., Makkonen, K.F., Aksenov, V.V., et al., Differential diagnosis of chronic sal**oophoritis and ovarian cancer based on immunological and discriminant methods, Klin. Lab. Diagn., 2017, vol. 62, no. 10, pp. 611–615.

    CAS  PubMed  Google Scholar 

  3. Antoneeva, I.I., The dynamics of the phagocytic activity of peripheral blood neutrophils during tumor progress in ovarian cancer, Vestn. Nov. Med. Tekhnol., 2007, no. 1, p. 119.

  4. Ashrafyan, L.A., Kiselev, V.I., Muizhnek, E.L., et al., Modern principles for the effective treatment of ovarian cancer, Opukholi Zhenskoi Reprod. Sist., 2015, no. 2, pp. 68–75.

  5. Blindar’, V.N., Zubrikhina, G.P., Zaryad’eva, E.A., et al., Functional characteristics of peripheral blood neutrophils in patients with ovarian cancer, Vestn. Ross. Onkol. Nauchn. Tsentra im. N.N. Blokhina,Ross. Akad. Med. Nauk, 2000, vol. 11, no. 2, pp. 46–52.

    Google Scholar 

  6. Bogdanova, E.M. and Urmancheeva, A.F., Ovarian cancer in elderly female patients, Sib. Onkol. Zh., 2011, no. 1, p. 18.

  7. Boginskaya, I.N., Salomatina, A.A., and Tatulov, E.B., Diagnostika opukholei i opukholevykh obrazovanii yaichnikov (Diagnostics of Tumors and Ovarian Tumor Neoplasms), Irkutsk: Irkutsk. Inf. Agentstvo, 2007, pp. 83–89.

  8. Borisova, M.A. and Agarkov, N.M., Mathematical methods in the differential diagnostics of ovarian cancer, Izv. Yugo-Zap. Gos. Univ., 2012, no. 2, pp. 267–271.

  9. Gening, T.P., Antoneeva, I.I., Abakumova, T.V., et al., Tumor-associated immunopathology in widespread ovarian cancer, Ul’yanovsk. Med.-Biol. Zh., 2013, no. 1, pp. 83–92.

  10. Gerfanova, E.V., Ashrafyan, L.A., Antonova, I.B., et al., Ovarian cancer screening: reality and prospects. A literature review, Opukholi Zhenskoi Reprod. Sist., 2015, no. 1, pp. 69–75.

  11. Granov, A.M. and Molchanov, O.E., Carcinogenesis and tumor immunobiology: fundamental and clinical aspects, Vopr. Onkol., 2008, no. 54, pp. 401–409.

  12. Dmitrieva, O.S., Shilovskiy, I.P., Khaitov, M.R., and Grivennikov, S.I., Interleukins 1 and 6 as main mediators of inflammation and cancer, Biochemistry (Moscow), 2016, vol. 81, no. 2, pp. 166–178.

    Google Scholar 

  13. Efremov, A.V., Matveevskii, N.A., Trunov, A.N., and Safronov, I.D., Specific features of humoral immunity in the blood of patients with uterus cancer, Opukholi Zhenskoi Reprod. Sist., 2011, no. 3, pp. 71–73.

  14. Zhordania, K.I., Kalinicheva, E.V., and Moiseev, A.A., Ovarian cancer: epidemiology, morphology, and histogenesis, Onkoginekologiya, 2017, no. 3, pp. 26–32.

  15. Zlatnik, E.Yu., Nerodo, G.A., Ardzha, A.Yu., et al., The role of immunological memory in the development of antitumor immunity in patients with ovarian cancer during neoadjuvant treatment, Vestn. Ross. Gos. Med. Univ., 2017, no. 5, pp. 63–73.

  16. Lavrova, V.S., Cherdyntseva, N.V., and Vasil’ev, N.V., Neitrofily i zlokachestvennyi rost (Neutrophils and Malignant Growth), Tomsk: Tomsk. Gos. Univ., 1992.

  17. Lozovoi, V.P. and Kozhevnikov, V.S., Metodicheskie rekomendatsii MZ SSSR (Methodological Recommendations of the Ministry of Health of USSR), Novosibirsk, 1990.

    Google Scholar 

  18. Mamarasulova, D.Z., Yuldasheva, N.Sh., and Mamadalieva, Ya.S., Antitumor immunity of patients with ovarian cancer, Klin. Onkol., 2017, no. 2, pp. 1–2.

  19. Mukhtarzhanova, Kh.N., Ziyaev, I.P., Abdurashidov, A.A., et al., Antitumor immunity of patients with ovarian cancer, Molodoi Uch., 2018, vol. 31, no. 217, pp. 42–44.

    Google Scholar 

  20. Novikov, V.V., Dobrotina, N.A., and Babaev, A.A., Immunologiya (Immunology), Nizhny Novgorod, 2005, pp. 144–145.

    Google Scholar 

  21. Khaitov, R.M. and Pinegin, B.V., Modern approaches to evaluation of the main stages of the phagocytic process, Immunologiya, 1995, no. 4, pp. 3–8.

  22. Shatalova, T.M., Kuznetsov, V.V., Blyumenberg, A.G., and Gorbunova, V.A., Ovarian cancer in older women, Vestn. Ross. Onkol. Nauchn. Tsentra im. N.N. Blokhina,Ross. Akad. Med. Nauk, 2003, vol. 14, no. 2, pp. 69–71.

    Google Scholar 

  23. Haskova, V., Kaslik, J., and Matl, I., Hovy zpusob stanoveni circulujieich imunokomplexu v lids-kych serech, Cas. Lek. Ces., 1977, vol. 116, pp. 436–437.

    CAS  Google Scholar 

  24. Husseinzadeh, N., Status of tumor markers in epithelial ovarian cancer has there been any progress? A review, Gynecol. Oncol., 2011, vol. 120, no. 1, pp. 152–157.

    Article  CAS  Google Scholar 

  25. Lowe, K.A., Chia, V.M., Taylor, A., et al., An international assessment of ovarian cancer incidence and mortality, Gynecol. Oncol., 2013, no. 130, pp. 107–114.

  26. Morgan, R.J., Armstrong, D.K., Alvarez, R.D., et al., Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology, J. Natl. Compr. Cancer Network, 2016, vol. 14, pp. 1134–1163.

    Article  Google Scholar 

  27. Prat, J., and FIGO Committee on Gynecologic Oncology, FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication, J. Gynecol. Oncol., 2015, vol. 26, no. 2, pp. 87–89.

    Article  CAS  Google Scholar 

  28. Schreiber, R.D., Old, L.J., and Smyth, M.J., Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion, Science, 2011, vol. 331, pp. 1565–1570.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. M. Agarkov.

Ethics declarations

Conflict of interests. The authors declare that they have no conflict of interest.

Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study.

Additional information

Translated by E. Sherstyuk

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agarkov, N.M., Kicha, D.I., Harchenko, V.V. et al. Laboratory Diagnostics of Ovarian Cancer among the Elderly Based on the Parameters of Immunoglobulins and Phagocytic Activity of Blood. Adv Gerontol 10, 57–61 (2020). https://doi.org/10.1134/S2079057020010026

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079057020010026

Keywords:

Navigation